| Study Period | 2020 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 126.20 Million |
| Market Size (2030) | USD 167.21 Million |
| CAGR (2025 - 2030) | 5.79 % |
| Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
China Electrocardiograph (ECG) Market Analysis
The China Electrocardiograph Market size is estimated at USD 126.20 million in 2025, and is expected to reach USD 167.21 million by 2030, at a CAGR of 5.79% during the forecast period (2025-2030).
An electrocardiograph (ECG or EKG) is a medical device used to record the heart's electrical activity. In China, the ECG market has been growing due to several factors, including the increasing prevalence of cardiovascular diseases, technological advancements, and greater awareness of heart health. In addition, the combination of a growing healthcare infrastructure and a rising focus on preventative healthcare is expected to drive the growth of the ECG market in China in the coming years.
The rise in the prevalence of cardiovascular diseases (CVDs) in China, partly due to lifestyle changes, the aging population, and urbanization, has increased the demand for ECG devices for early diagnosis and monitoring. For instance, data from the National Health Commission's Coronary Heart Disease Intervention Technology Quality Control Center, updated in 2023, reveals a rise in ST-elevation myocardial infarction (STEMI) cases, jumping from 163,451 in 2022 to 177,598 in 2023. This uptick underscores the mounting challenge of cardiac diseases, likely driving heightened demand for ECG monitoring devices and fueling market growth during the study period.
Innovations in ECG technology have significantly enhanced accessibility for healthcare providers and patients, making these tools easier to use. These advancements in devices, which offer improved accuracy, connectivity, and user-friendliness, are directly influencing the market dynamics. For instance, in December 2024, researchers at the University of Science and Technology of China achieved progress in non-contact cardiac activity perception. They utilized the "beat frequency effect," a critical physical phenomenon, to analyze the harmonics of cardiac mechanical activity. Such technological breakthroughs, emphasizing non-contact convenience and high precision, are increasing the adoption of ECG monitoring devices, thereby driving market growth.
The increasing prevalence of cardiac problems, coupled with advancements in ECG device technology, is anticipated to drive market growth over the forecast period. However, the high cost associated with advanced ECG devices may act as a barrier, potentially limiting the market's expansion in the country during the same period.
China Electrocardiograph (ECG) Market Trends
Holter ECG Systems Segment is Expected to Have Significant Growth in the Market Over the Forecast Period
China's electrocardiograph (ECG) market is witnessing a notable surge in the Holter ECG systems segment, driven by its critical role in addressing evolving healthcare needs. This growth reflects trends such as the increasing demand for continuous cardiac monitoring, advancements in Holter monitor technology, and rising public awareness of cardiovascular conditions. These factors highlight the segment's importance in meeting the growing demand for efficient and accurate diagnostic tools within the broader ECG market.
Holter monitors, which record ECG data continuously for 24 to 48 hours or longer, play a critical role in the cardiac monitoring market by enabling the detection of intermittent arrhythmias and other cardiac issues that standard ECGs might miss. This extended monitoring capability is essential for diagnosing sporadic conditions that are not evident during brief examinations. For example, data from THOTH (Suzhou) Medical in 2024 indicates that hospital outpatient clinics predominantly rely on the 24-hour dynamic electrocardiogram, commonly known as Holter, as a non-invasive solution for arrhythmia detection. In comparison, traditional ECGs, which capture a patient's signal for only 10 seconds, face limitations in addressing such diagnostic needs, further emphasizing the growing demand for Holter monitors in the market.
Due to the sudden and transient nature of heart conditions, traditional ECGs often fail to detect arrhythmias, which can lead to diagnostic oversights. Holter ECG monitors address this gap through continuous monitoring, offering a more reliable solution for detecting such conditions. This advantage is expected to drive the increasing adoption of Holter monitors, thereby contributing to the growth of this market segment over the forecast period.
Furthermore, the COVID-19 pandemic in China significantly accelerated the adoption of telemedicine, driving the demand for remote monitoring solutions. This trend has directly impacted the market for Holter monitors, as these devices are highly compatible with telehealth applications. They allow physicians to remotely analyze patient readings and provide timely interventions, enhancing the efficiency of healthcare delivery. Consequently, the increasing reliance on continuous cardiac monitoring through Holter monitors, combined with the expanding telemedicine market, is expected to drive the growth of this segment in the country over the study period.
Understand The Key Trends Shaping This Market
Download PDF
ECG Management Software is Expected to Have Fastest Growth in the Market Over the Forecast Period
ECG management software, a specialized application, enables healthcare providers to record, manage, analyze, and store electrocardiogram (ECG) data efficiently. The growing market for ECG management software in China is closely tied to the increasing adoption of digital health technologies, which streamline healthcare operations and improve patient outcomes. Additionally, the rising demand for efficient electronic health record (EHR) management and the ongoing expansion of healthcare services are driving market growth. Furthermore, innovations in artificial intelligence (AI), machine learning (ML), and cloud-based solutions are enhancing the functionality of ECG management software, making it a critical tool across various healthcare settings and further accelerating its adoption.
ECG management software plays a crucial role in population health initiatives by enabling the monitoring of at-risk patients and the proactive management of chronic conditions, such as those requiring percutaneous coronary intervention (PCI) for heart disease. The growing adoption of this software aligns with the increasing demand for efficient healthcare solutions in the market. For instance, the National Health Commission reported that mainland China registered 1.63 million coronary intervention cases in 2023. This figure was derived from two primary sources: online direct reporting, which accounted for 865,126 cases, and supplementary data verified by provincial quality control centers, totaling 770,929 cases. The PCI segment demonstrated significant market growth, with a robust increase of 26.44% in 2023 compared to 2022. Provinces such as Hebei, Beijing, Henan, Shandong, and Zhejiang led in case numbers, reflecting regional trends that could influence market dynamics and demand for ECG management solutions.
The increasing frequency of coronary interventions, which require continuous monitoring supported by historical data, is significantly driving the demand for ECG software. This growing reliance on ECG software to manage cardiac activities is directly contributing to the expansion of this market segment over the forecast period.
Get Analysis on Important Geographic Markets
Download PDF
China Electrocardiograph (ECG) Industry Overview
The competitive landscape of the electrocardiograph (ECG) market in China is characterized by a mix of established companies and emerging players. The market is moderately consolidated yet dynamically competitive. Additionally, many companies offer specialized solutions, contributing to a vibrant and evolving ecosystem. Some of the major players in the market include EDAN Instruments, Inc., Nihon Kohden Corporation, Koninklijke Philips N.V., SCHILLER, Lepu Medical Technology(Beijing)Co.,Ltd., among others.
China Electrocardiograph (ECG) Market Leaders
-
Lepu Medical Technology(Beijing)Co.,Ltd.
-
EDAN Instruments, Inc
-
Nihon Kohden Corporation
-
Koninklijke Philips N.V.
-
SCHILLER
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
China Electrocardiograph (ECG) Market News
- July 2024: Beijing Winnie Huili Medical Equipment Co., Ltd, a marketing agent for Welch Allyn, Inc., has received approval from the National Medical Products Administration (NMPA) for its Electrocardiograph (ECG) device, registered under Certificate Number 20142075933. This approval highlights the company's role in expanding the availability of advanced ECG devices in the medical equipment market.
- May 2024: Shenzhen Kaiwoer Electronics Co., Ltd has received approval from the National Medical Products Administration (NMPA) for its Multi-channel ECG machine, registered under Certificate Number 20213070059. This approval positions the company to strengthen its presence in the medical devices market, particularly in the diagnostic equipment segment.
China Electrocardiograph (ECG) Industry Segmentation
As per the scope of the report, an electrocardiograph (ECG) is a medical device used to record the heart's electrical activity. The device captures the heart's electrical signals and produces a graphical representation known as an electrocardiogram.
The China ECG market report provides a comprehensive analysis of the current state and growth potential of the ECG market in the country. The China electrocardiograph (ECG) market is segmented by product type, which includes resting (12-lead ECG) systems, stress ECG systems, Holter ECG systems, and ECG management software. The report offers the market size in terms of both value (in USD) and volume (in units) for the above segments.
| By Product Type | Resting ECG Systems |
| Stress ECG Systems | |
| Holter ECG Systems | |
| ECG Management Software |
Need A Different Region or Segment?
Customize Now
China Electrocardiograph (ECG) Market Research FAQs
How big is the China Electrocardiograph Market?
The China Electrocardiograph Market size is expected to reach USD 126.20 million in 2025 and grow at a CAGR of 5.79% to reach USD 167.21 million by 2030.
What is the current China Electrocardiograph Market size?
In 2025, the China Electrocardiograph Market size is expected to reach USD 126.20 million.
Who are the key players in China Electrocardiograph Market?
Lepu Medical Technology(Beijing)Co.,Ltd., EDAN Instruments, Inc, Nihon Kohden Corporation, Koninklijke Philips N.V. and SCHILLER are the major companies operating in the China Electrocardiograph Market.
What years does this China Electrocardiograph Market cover, and what was the market size in 2024?
In 2024, the China Electrocardiograph Market size was estimated at USD 118.89 million. The report covers the China Electrocardiograph Market historical market size for years: 2020, 2021, 2022, 2023 and 2024. The report also forecasts the China Electrocardiograph Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
China Electrocardiograph (ECG) Industry Report
Statistics for the 2025 China Electrocardiograph (ECG) market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. China Electrocardiograph (ECG) analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
